Cefadroxil 500 mg Capsules in Normal Healthy Non-Smoking Male and Female Subjects.
Clinical trial NCT00835081 · COMPLETED
Trial details
- NCT number
- NCT00835081
- Sponsor
- Teva Pharmaceuticals USA
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-09-01
- Primary completion
- 2004-10-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.